2 results
6-K
EX-99
BLRX
Bioline Rx Ltd
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
Cancer.
“We are tremendously pleased by the swift closing of this significant licensing agreement for the Asian market, which brings substantial
6-K
EX-99
BLRX
Bioline Rx Ltd
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
substantial upside potential on the partnered programs. We also see significant potential for further enhancing our presence in the Asian pharmaceutical
- Prev
- 1
- Next